Researchers report discovery of ROR-107, a GPBAR1 agonist and RORγt inverse agonist for IBD
May 12, 2023
Inflammatory bowel disease (IBD) is a chronic, immunologically mediated disorder of the gastrointestinal tract in which tissue damage and sustained inflammation lead to long-term dysfunction of the gastrointestinal tract.
